Papers
1
Total Citations
15
H-Index
1
About
Ren Sun is a translational cancer researcher whose work focuses on identifying therapeutic vulnerabilities in head and neck squamous cell carcinoma (HNSCC), with a particular emphasis on the distinct biology of human papillomavirus (HPV)-positive and HPV-negative disease. In their landmark 2018 study, which has garnered 15 citations, Sun led a high-throughput drug screening effort that systematically tested hundreds of compounds across HPV-positive and HPV-negative HNSCC cell lines. This work revealed agents with preferential activity against each subtype, providing a critical framework for personalized treatment strategies in head and neck cancer. By demonstrating that HPV status dictates differential drug sensitivity, Sun’s research has directly informed the design of more targeted clinical trials and highlighted the potential for repurposing existing drugs. Their contributions bridge the gap between preclinical discovery and clinical application, offering new hope for patients with these aggressive malignancies. Sun’s collaborative, multi-institutional approach—integrating expertise from oncology, virology, and functional genomics—exemplifies the power of team science in tackling complex cancers.
Research Focus
Key Achievements
Top Papers
- 1